Back to today’s briefing

Story perspectives

Revolutionary Non-Opioid Drug Offers Safer Pain Relief

5/21/2025

41 9

Summary

Story summary

SBI-810, a groundbreaking non-opioid pain relief drug from Duke University, targets neurotensin receptor 1 to provide effective pain alleviation without the risks of tolerance or sedation. This innovative treatment not only surpasses current medications but also enhances the effectiveness of opioids at lower doses, offering a safer, non-addictive alternative for those in pain.

1 of 1

Story summary

SBI-810, a groundbreaking non-opioid pain relief drug from Duke University, targets neurotensin receptor 1 to provide effective pain alleviation without the risks of tolerance or sedation. This innovative treatment not only surpasses current medications but also enhances the effectiveness of opioids at lower doses, offering a safer, non-addictive alternative for those in pain.